Breast Edema after Conservative Surgery for Early-Stage Breast Cancer: A Retrospective Single-Center Assessment of Risk Factors.

breast cancer breast conserving surgery breast edema lymphedema

Journal

Lymphology
ISSN: 2522-7963
Titre abrégé: Lymphology
Pays: United States
ID NLM: 0155112

Informations de publication

Date de publication:
2022
Historique:
medline: 1 1 2022
pubmed: 1 1 2022
entrez: 8 8 2023
Statut: ppublish

Résumé

Breast-conserving surgery (BCS) is the standard of care for early-stage breast cancer. We retrospectively enrolled 530 patients (mean age: 62.96 ± 12.69 years) undergoing BCS between January 1, 2018, and December 31, 2019. During the COVID-19 pandemic, all patients with at least 1 year of follow-up were telephonically asked after surgery to provide clinical signs and symptoms attributable to postoperative breast cancer-related lymphedema of the breast (BCRL-B). Thirty-one (5.8%) patients reported breast edema and were visited to measure the tissue dielectric constant (TDC) and to assess the induration of the skin. There was a difference seen in treatment with lumpectomy + ALND performed more frequently in patients with (29%) than without (12%) BCRL-B. In the subgroup of patients with BCRL-B (n=31), significantly higher values of local total water were calculated in the nine patients who underwent Lump + ALND procedure (1.86 ± 0.48 vs. 1.48 ± 0.38; p = 0.046). Among patients with BCRL-B (n=31), in eight patients (25.8%) tissue induration measured with SkinFibroMeter was >0.100 N, thus suggesting tissue fibrosis. Cumulative survival probability at 1-year after surgery was 0.992. No statistical differences in 1-year survival after surgery were found for type of surgery (p = 0.890) or absence/presence of BCRL-B (p = 0.480). In univariate logistic regression, only lumpectomy + ALND surgery (p = 0.009) and any subsequent axillary lymph node removal surgery (p = 0.003) were associated with BCRL-B. Both of these variables were also found to be statistically significant in the multivariate regression model. Further prospective research is warranted to analyze potentential predictors of BCRL-B and to reduce/ prevent this complication.

Identifiants

pubmed: 37553005

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

167-177

Informations de copyright

Copyright by International Society of Lymphology.

Déclaration de conflit d'intérêts

The authors of this article and the planning committee members and staff have no relevant financial relationships with commercial interests to disclose.

Auteurs

C Cornacchia (C)

Department of Onco-Hematology - Breast Surgery Clinic, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

S Dessalvi (S)

Department of Surgical Sciences and Integrated Diagnostics (DISC) - Unit of Lymphatic Surgery, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

G Santori (G)

Department of Surgical Sciences and Integrated Diagnostics (DISC), University of Genoa, Genoa, Italy.

F Canobbio (F)

School of Medicine, University of Genoa, Genoa, Italy.

G Atzori (G)

Department of Onco-Hematology - Breast Surgery Clinic, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

F De Paoli (F)

Department of Onco-Hematology - Breast Surgery Clinic, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

R Diaz (R)

Department of Onco-Hematology - Breast Surgery Clinic, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

S Franchelli (S)

Department of Onco-Hematology - Breast Surgery Clinic, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

M Gipponi (M)

Department of Onco-Hematology - Breast Surgery Clinic, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

F Murelli (F)

Department of Onco-Hematology - Breast Surgery Clinic, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

M Sparavigna (M)

Department of Onco-Hematology - Breast Surgery Clinic, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

F Pitto (F)

Department of Laboratory Diagnostics - Pathology Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

A Fozza (A)

Department of Diagnostic Imaging and Radiotherapy - Unit of Radiation Oncology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

F Boccardo (F)

Department of Surgical Sciences and Integrated Diagnostics (DISC) - Unit of Lymphatic Surgery, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

D Friedman (D)

Department of Onco-Hematology - Breast Surgery Clinic, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

P Fregatti (P)

Department of Onco-Hematology - Breast Surgery Clinic, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.

Classifications MeSH